Australian Clinical Labs Limited

ASX:ACL Stock Report

Market Cap: AU$685.1m

Australian Clinical Labs Future Growth

Future criteria checks 3/6

Australian Clinical Labs is forecast to grow earnings and revenue by 16% and 4.7% per annum respectively. EPS is expected to grow by 16.2% per annum. Return on equity is forecast to be 25% in 3 years.

Key information

16.0%

Earnings growth rate

16.2%

EPS growth rate

Healthcare earnings growth24.1%
Revenue growth rate4.7%
Future return on equity25.0%
Analyst coverage

Good

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge

Sep 03
Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge

Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?

Sep 02
Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?

We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Jun 20
We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Feb 21
Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Dec 08
Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Aug 14
Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 25
Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

Dec 22
New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

Dec 21
The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Sep 01
The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Earnings and Revenue Growth Forecasts

ASX:ACL - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202780548521867
6/30/202677143481798
6/30/202573637451648
6/30/202469624153160N/A
3/31/202468520150157N/A
12/31/202367415147154N/A
9/30/202368626142149N/A
6/30/202369736137144N/A
3/31/202375755143154N/A
12/31/202281873148165N/A
9/30/2022907126206225N/A
6/30/2022996178263284N/A
3/31/2022931156238256N/A
12/31/2021867134214228N/A
9/30/202175797179191N/A
6/30/202164760144154N/A
3/31/202159879N/AN/AN/A
12/31/202054998N/AN/AN/A
9/30/202052070N/AN/AN/A
6/30/20204914192102N/A
6/30/2019448-11-131N/A
6/30/2018379-9-45N/A
6/30/2017340-24N/A5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ACL's forecast earnings growth (16% per year) is above the savings rate (2.6%).

Earnings vs Market: ACL's earnings (16% per year) are forecast to grow faster than the Australian market (12.6% per year).

High Growth Earnings: ACL's earnings are forecast to grow, but not significantly.

Revenue vs Market: ACL's revenue (4.7% per year) is forecast to grow slower than the Australian market (5.8% per year).

High Growth Revenue: ACL's revenue (4.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ACL's Return on Equity is forecast to be high in 3 years time (25%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 23:16
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Australian Clinical Labs Limited is covered by 12 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Lyanne HarrisonBofA Global Research
Mathieu ChevrierCitigroup Inc